Stay updated with breaking news from High Acuity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Comerica Bank increased its stake in shares of Amedisys, Inc. (NASDAQ:AMED – Get Rating) by 2.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,500 shares of the health services provider’s stock after buying an additional 345 shares during […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Equities research analysts expect Amedisys, Inc. (NASDAQ:AMED – Get Rating) to post $580.91 million in sales for the current fiscal quarter, Zacks reports. Eight analysts have issued estimates for Amedisys’ earnings. The highest sales estimate is $592.20 million and the lowest is $560.70 million. Amedisys reported sales of $564.17 million in the same quarter last […]
Shares of Amedisys, Inc. (NASDAQ:AMED – Get Rating) have earned an average recommendation of “Buy” from the eighteen analysts that are covering the firm, MarketBeat.com reports. Seven investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 1 year price target among analysts […]
Amedisys (NASDAQ:AMED – Get Rating) had its target price reduced by analysts at SVB Leerink from $131.00 to $117.00 in a note issued to investors on Friday, Stock Target Advisor reports. The brokerage currently has a “market perform” rating on the health services provider’s stock. SVB Leerink’s price target points to a potential downside of […]